Abstract
The immune system plays an essential role in the pathogenesis, prevention and treatment of infectious diseases. Immunoinfectomics is an emerging field that addresses the interface between the host immune system and pathogens, and studies immunomes and infectomes (immunoinfectomes). Immune responses induced by microbial infections are complex phenomena that supervene on the levels of genomes, and as a result, infection and immunity ultimately depend on immunoinfectomes. The computational and mathematical approaches have shown practical benefits to convert all these complex data into sophisticated computer models of cellular gene and protein networks. The availability of the above methods has resulted in exciting new progress in the discovery and development of drugs and vaccines against infectious diseases with immunoinfectomic approaches. It has been demonstrated that only one single variable domain antibody fragment, referred to as VHH (variable heavy chain antibody) or nanobody, can interact with antigens. Nanobodies display several characteristics superior to the conventional antibodies, including their non-immunogenicity and high thermal and chemical stability. These characteristics make nanobodies strong candidates as targeting agents for infectious diseases. Recently, tremendous progress has been made in immune epitope mapping and vaccine candidate identification through the use of the immunoinfectomic approaches. These omic approaches provide powerful tools for advances in system biology of microbial infections and the discovery of novel antimicrobial agents.
Keywords: Alarmins, epitope, immunomes, infectomes, immunoinfectomes, nanobody, vaccine.
Anti-Infective Agents
Title:Exploring Novel Immunological Interventions Using Immunoinfectomics
Volume: 11 Issue: 2
Author(s): Qiqi Zhu, Lin Wang, Suoqin Tang, Hong Cao and Sheng-He Huang
Affiliation:
Keywords: Alarmins, epitope, immunomes, infectomes, immunoinfectomes, nanobody, vaccine.
Abstract: The immune system plays an essential role in the pathogenesis, prevention and treatment of infectious diseases. Immunoinfectomics is an emerging field that addresses the interface between the host immune system and pathogens, and studies immunomes and infectomes (immunoinfectomes). Immune responses induced by microbial infections are complex phenomena that supervene on the levels of genomes, and as a result, infection and immunity ultimately depend on immunoinfectomes. The computational and mathematical approaches have shown practical benefits to convert all these complex data into sophisticated computer models of cellular gene and protein networks. The availability of the above methods has resulted in exciting new progress in the discovery and development of drugs and vaccines against infectious diseases with immunoinfectomic approaches. It has been demonstrated that only one single variable domain antibody fragment, referred to as VHH (variable heavy chain antibody) or nanobody, can interact with antigens. Nanobodies display several characteristics superior to the conventional antibodies, including their non-immunogenicity and high thermal and chemical stability. These characteristics make nanobodies strong candidates as targeting agents for infectious diseases. Recently, tremendous progress has been made in immune epitope mapping and vaccine candidate identification through the use of the immunoinfectomic approaches. These omic approaches provide powerful tools for advances in system biology of microbial infections and the discovery of novel antimicrobial agents.
Export Options
About this article
Cite this article as:
Zhu Qiqi, Wang Lin, Tang Suoqin, Cao Hong and Huang Sheng-He, Exploring Novel Immunological Interventions Using Immunoinfectomics, Anti-Infective Agents 2013; 11 (2) . https://dx.doi.org/10.2174/2211352511311020004
DOI https://dx.doi.org/10.2174/2211352511311020004 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
Call for Papers in Thematic Issues
An Overview of Drugs for Multiple Targets and Variants of SARS-CoV-2 Through Artificial Intelligence, Machine Learning, Deep Learning, and Experimental Analysis
The emergence and rapid evolution of SARS-CoV-2 variants have posed significant challenges in the ongoing fight against the COVID-19 pandemic. The development of effective treatments for multiple viral targets and variants demands innovative approaches, including artificial intelligence (AI), machine learning (ML), and deep learning (DL) techniques. This special issue aims ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Antitumor and Antiviral Activity of Pentacyclic Triterpenes
Mini-Reviews in Organic Chemistry Atypical Chest Pain in ACS: A Trap Especially for Women
Current Pharmaceutical Design Role of mTOR Signaling in Tumor Cell Motility, Invasion and Metastasis
Current Protein & Peptide Science NAD<sup>+</sup>-Dependent Enzymes at the Endoplasmic Reticulum
Current Topics in Medicinal Chemistry Essential Roles of Toll-Like Receptors in Atherosclerosis
Current Medicinal Chemistry Molecular Targeting of Lymphatics for Therapy
Current Pharmaceutical Design FHIT and p53 Status and Response to Platinum-Based Treatment in Advanced Non-Small Cell Lung Cancer
Current Cancer Drug Targets A Novel Marine Drug, SZ–685C, Induces Apoptosis of MMQ Pituitary Tumor Cells by Downregulating miR–200c
Current Medicinal Chemistry Telomeres and Thyroid Cancer
Current Genomics Effectivity of Long Antigen Exposition Dendritic Cell Therapy (LANEXDC<sup>®</sup>) in the Palliative Treatment of Pancreatic Cancer
Current Medicinal Chemistry Unfoldomics of Human Genetic Diseases: Illustrative Examples of Ordered and Intrinsically Disordered Members of the Human Diseasome
Protein & Peptide Letters Current Developments Using Emerging Transdermal Technologies In Physical Enhancement Methods.
Current Drug Delivery Targeted Radionuclide Therapy of Painful Bone Metastases: Past Developments, Current Status, Recent Advances and Future Directions
Current Medicinal Chemistry Synthesis and Biological Evaluation of Novel Thionucleosides
Current Organic Chemistry Erlotinib: A Targeted Anticancer Drug
Current Cancer Therapy Reviews Emerging Technologies for Fertility Preservation in Female Patients
Current Women`s Health Reviews Circulating Levels of VCAM and MMP-2 May Help Identify Patients with More Aggressive Prostate Cancer
Current Cancer Drug Targets Computer-aided Diagnosis of Melanoma: A Review of Existing Knowledge and Strategies
Current Medical Imaging Therapeutic Intervention in Cancer and Chronic Viral Infections: Antibody Mediated Manipulation of PD-1/PD-L1 Interaction
Reviews on Recent Clinical Trials Targeting Invasion Induction as a Therapeutic Strategy for the Treatment of Cancer
Current Cancer Drug Targets